allergies

Pharma By Ed Silverman

Pharmalittle: Pfizer and BioNTech start trial of Omicron-targeted vaccine; insulin makers boost lobbying spending

Biotech By Adam Feuerstein

Pivotal study shows Sierra Oncology drug improves anemia and other symptoms of myelofibrosis

Health By Matthew Herper

As Pfizer and BioNTech begin clinical trial of Omicron-based vaccine, timeline to authorization is unclear

First Opinion By Amir Mokhtari

Learning from Covid-19 requires a modeling renaissance

Opinions+ By Jim King and Philip Burton

What’s blocking health care boards’ progress in diversity, equity, and inclusion?

Health Tech By Katie Palmer

Can open datasets help machine learning solve medical mysteries?

Health By Nicholas Florko and Andrew Joseph

It’s too early to tell whether CBD helps against Covid-19 — but researchers worry that won’t stop CBD makers

Politics By Rachel Cohrs

Insulin giants Eli Lilly and Novo Nordisk boosted their lobbying spending as Democrats eyed pricing reform